As a longtime friend of a Viral Myocarditis survivor and heart transplant recipient, and a supporter of the Myocarditis Foundation, I have been able to learn extensively about the impact Myocarditis can have and the randomness of the disease itself. I believe passionately that the efforts of the foundation can serve as a catalyst to reduce such randomness, and work towards more preventative measures to predict and combat Myocarditis.
Brief info
Credentials: Michael A. Linn is a Sales Leader for the Instruments division of the Stryker Corporation where he currently manages a team responsible for the New York Orthopedic business. With Stryker since 2005, his extensive background extends to the facial trauma/reconstruction, neurosurgery, and cardiothoracic fields as well. Michael has worked with top hospitals throughout the Northeast, and brings a substantial Healthcare and Medical Device network to the Myocarditis Foundation